Overview

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability and the PK/PD relationship of BMS-767778 administered as single and multiple oral doses in healthy subjects, and in subjects with T2DM
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb